Researchers have identified a metabolically sensitive cell subtype in the eye’s drainage system which shows early signs of dysfunction in a genetic mouse model of glaucoma.
MORGANTOWN, W.Va., Jan. 20, 2026 /PRNewswire/ — Omnia Medical, a medical technology company developing surgical solutions for spine and interventional pain physicians, today announced the commercial launch of its FDA-cleared PsiF DNA™ Sacroiliac Joint Stabilization System.
LOS GATOS, Calif., Jan. 20, 2026 /PRNewswire/ — In the pivotal clinical trial of their technology, researchers at Orlucent®, Inc. have confirmed the accuracy of the company’s Skin Fluorescent Imaging (SFI) System, a non-invasive, hand-held molecular imaging device for the direct, on-the-skin, point-of-care assessment of suspicious moles and early detection of melanoma-related activity.
FDA-cleared PCR test aids in detection of 11 diarrhea-causing bacteria, viruses, and parasites from 1 sample
People with spinal cord injuries often lose some or all their limb function. In most patients, the nerves in their limbs work fine, and the neurons in their brain are still operational, but the damage to their spinal cords prevents the two areas from communicating.
The FDA-approved comprehensive genomic profiling test will be reimbursed at a rate of $2,989.55 per test, helping to advance adoption in the US healthcare system
About 1 million Americans suffer from Parkinson’s disease, with around 90,000 new cases diagnosed each year, according to the Parkinson’s Foundation. The chronic, degenerative brain disorder destroys dopamine-producing cells essential for smooth, coordinated movement.
Abbott (NYSE: ABT)+
announced today that it received CE mark for its TactiFlex Duo Ablation Catheter, Sensor-Enabled, to treat AFib.
A research team has made a breakthrough in epigenetic drug discovery. The researchers have successfully developed a first-in-class chemical inhibitor that precisely and selectively targets the ATAC complex, a critical cellular “switch operator” that activates tumor-promoting genes, opening a novel therapeutic avenue for non-small cell lung cancer (NSCLC).
A Europe-wide study led by the University Medical Center Göttingen (UMG) shows that the microbial composition of the gut, known as the gut microbiome, can predict long-term complications following severe acute pancreatitis.